Detalhe da pesquisa
1.
ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia treatment resistance.
Mol Biol Rep
; 46(4): 3747-3754, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025148
2.
The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression.
Immunobiology
; 226(1): 152049, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352400
3.
B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles.
Front Oncol
; 10: 264, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32231996